Notably, our study exhibited that EBV infection did not impact the efficacy of ICI treatment, despite the frequent association of EBV infection with high PD-L1 expression in tumors was discovered [25, 26]. The gene discussed is CD274; the disease is Epstein-Barr virus infection.